title: Pharmacological effects of gastric inhibitory polypeptide, cholecystokinin, and somatostatin on the serum levels of cationic trypsin-like immunoreactivity in man.
abstract: In six healthy volunteers there were no significant changes during a 300-min control period, whereas gastric inhibitory polypeptide in pharmacological doses first caused a transient and non-significant decrease and then a significant increase in the serum cationic trypsin-like immunoreactivity (CTLI). In another two groups of six healthy subjects, pharmacological doses of cholecystokinin elicited a non-significant increase, whereas somatostatin in pharmacological doses first caused a significant decrease and then a rebound effect with significantly higher levels of serum CTLI.
authors.forename: J
authors.initials: J
authors.lastname: Florholmen
authors.forename: P G
authors.initials: PG
authors.lastname: Burhol
authors.forename: T G
authors.initials: TG
authors.lastname: Jenssen
authors.forename: R
authors.initials: R
authors.lastname: Jorde
mesh_terms: D000328:Adult; D002766:Cholecystokinin / Q000494:pharmacology*; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010186:Pancreatic Function Tests; D013004:Somatostatin / Q000494:pharmacology*; D014357:Trypsin / Q000097:blood*
chemical_list: D013004:Somatostatin; D005749:Gastric Inhibitory Polypeptide; D002766:Cholecystokinin; D014357:Trypsin